Add to ORKGThe present invention is drawn to methods of enhancing bioavailability, pulmonary absorption and/or optimal dosing of a biologically active agent. The methods of the invention enhance the pulmonary absorption and bioavailability of a biologically active agent by administering to the pulmonary system of a subject, a biologically active agent and a macrophage inhibiting agent that is suitable for administration to a subject's pulmonary syste
The fraction of an inhaled toxic compound which penetrates the upper airways to the lung parenchyma ...
While the inhalation route has been used for millennia for pharmacologic effect, the biological barr...
The human lung is an effective route for noninvasive drug delivery because it provides a large surfa...
The present invention relates to a compound comprising one or more PEG moieties , wherein said compo...
publication date: 2019-05-30; filing date: 2019-01-31The present invention relates to a compound com...
Inhalable compositions are described. The inhalable compositions comprise one or more respirable agg...
The present invention provides a method of improving the efficiency of absorption into the bloodstre...
Particles incorporating a surfactant and/or a hydrophilic or hydrophobic complex of a positively or ...
Particles incorporating a surfactant and/or a hydrophilic or hydrophobic complex of a positively or ...
The invention generally relates to a method for pulmonary delivery of therapeutic, prophylactic and ...
Pulmonary administration route has been extensively exploited for the treatment of local lung diseas...
The invention generally relates to a method for pulmonary delivery of therapeutic, prophylactic and ...
The pulmonary route of drug delivery can provide an excellent alternative to other routes both for l...
Mucoadhesive based pulmonary drug delivery is an advanced novel intervention against several pulmona...
Provided herein are vaccine vectors including an antigenic polypeptide and an HMGB1 polypeptide pres...
The fraction of an inhaled toxic compound which penetrates the upper airways to the lung parenchyma ...
While the inhalation route has been used for millennia for pharmacologic effect, the biological barr...
The human lung is an effective route for noninvasive drug delivery because it provides a large surfa...
The present invention relates to a compound comprising one or more PEG moieties , wherein said compo...
publication date: 2019-05-30; filing date: 2019-01-31The present invention relates to a compound com...
Inhalable compositions are described. The inhalable compositions comprise one or more respirable agg...
The present invention provides a method of improving the efficiency of absorption into the bloodstre...
Particles incorporating a surfactant and/or a hydrophilic or hydrophobic complex of a positively or ...
Particles incorporating a surfactant and/or a hydrophilic or hydrophobic complex of a positively or ...
The invention generally relates to a method for pulmonary delivery of therapeutic, prophylactic and ...
Pulmonary administration route has been extensively exploited for the treatment of local lung diseas...
The invention generally relates to a method for pulmonary delivery of therapeutic, prophylactic and ...
The pulmonary route of drug delivery can provide an excellent alternative to other routes both for l...
Mucoadhesive based pulmonary drug delivery is an advanced novel intervention against several pulmona...
Provided herein are vaccine vectors including an antigenic polypeptide and an HMGB1 polypeptide pres...
The fraction of an inhaled toxic compound which penetrates the upper airways to the lung parenchyma ...
While the inhalation route has been used for millennia for pharmacologic effect, the biological barr...
The human lung is an effective route for noninvasive drug delivery because it provides a large surfa...